Vivani Medical Inc VANI Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Nov 08, 2024 (filed on Nov 13, 2024)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

3,968,253

Price:

$1.26
Oct 03, 2024 (filed on Oct 03, 2024)

Insider Name:

Dwyer Donald

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

500

Price:

$1.13
Oct 02, 2024 (filed on Oct 03, 2024)

Insider Name:

Dwyer Donald

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,000

Price:

$1.13
Oct 01, 2024 (filed on Oct 03, 2024)

Insider Name:

Dwyer Donald

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,000

Price:

$1.14
Jul 31, 2024 (filed on Aug 01, 2024)

Insider Name:

Dwyer Donald

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

4,000

Price:

$1.23
Jul 30, 2024 (filed on Aug 01, 2024)

Insider Name:

Dwyer Donald

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

5,000

Price:

$1.24
Jun 27, 2024 (filed on Jul 01, 2024)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock Option

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

34,839

Price:

--
Jun 27, 2024 (filed on Jul 01, 2024)

Insider Name:

Baker Wilford Dean

Ownership Type:

Direct Ownership

Securities:

Common Stock Option

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

34,839

Price:

--
Jun 27, 2024 (filed on Jul 01, 2024)

Insider Name:

Bradbury Daniel

Ownership Type:

Direct Ownership

Securities:

Common Stock Option

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

34,839

Price:

--
Jun 27, 2024 (filed on Jul 01, 2024)

Insider Name:

Larson Alexandra L.P.

Ownership Type:

Direct Ownership

Securities:

Common Stock Option

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

34,839

Price:

--

Filings by filing date

Nov 08, 2024 (filed on Nov 13, 2024)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

3,968,253

Price:

$1.26
Oct 03, 2024 (filed on Oct 03, 2024)

Insider Name:

Dwyer Donald

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

500

Price:

$1.13
Oct 02, 2024 (filed on Oct 03, 2024)

Insider Name:

Dwyer Donald

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,000

Price:

$1.13
Oct 01, 2024 (filed on Oct 03, 2024)

Insider Name:

Dwyer Donald

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,000

Price:

$1.14
Jul 31, 2024 (filed on Aug 01, 2024)

Insider Name:

Dwyer Donald

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

4,000

Price:

$1.23
Jul 30, 2024 (filed on Aug 01, 2024)

Insider Name:

Dwyer Donald

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

5,000

Price:

$1.24
Nov 22, 2023 (filed on Aug 01, 2024)

Insider Name:

Dwyer Donald

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

2,000

Price:

$0.96
Jun 27, 2024 (filed on Jul 01, 2024)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock Option

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

34,839

Price:

--
Jun 27, 2024 (filed on Jul 01, 2024)

Insider Name:

Baker Wilford Dean

Ownership Type:

Direct Ownership

Securities:

Common Stock Option

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

34,839

Price:

--
Jun 27, 2024 (filed on Jul 01, 2024)

Insider Name:

Bradbury Daniel

Ownership Type:

Direct Ownership

Securities:

Common Stock Option

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

34,839

Price:

--

News

Biz Brief

Sector: Healthcare	Industry: Medical Equipment, Supplies & Distribution

See Regulatory Filings on SEC

Company Contact

Address:	1350 S. Loop Road ALAMEDA CA 94502
Tel:	N/A
Website:	https://vivani.com
IR:	See website

Key People

Adam Mendelsohn Chief Executive Officer, Director	Brigid A. Makes Chief Financial Officer	Truc Le Chief Operating Officer
Ted Randolph Vice President - Operations	Donald Dwyer Chief Business Officer	Lisa Porter Chief Medical Officer

Business Overview

Vivani Medical, Inc. is a biopharmaceutical company developing novel, ultra-long-acting drug implants. Leveraging its NanoPortal platform, the Company develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Its lead program, NPM-115, utilizes a miniature, six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of chronic weight management in obese or overweight individuals. Its pipeline also includes the NPM-139 (semaglutide) implant which is also under development for chronic weight management in obese and overweight individuals. NPM-119 refers to its Type II diabetes development program. OKV-119 is an exenatide implant that is under development for metabolic diseases in cats, including for the treatment of obesity and diabetes. Its segments include Biopharm Division and Neurostimulation Division.

Financial Overview

For the nine months ended 30 September 2024, Vivani Medical Inc revenues was not reported. Net loss decreased 11% to $17.4M. Lower net loss reflects General and administrative decrease of 20% to $6.3M (expense), Research and Development, net decrease of 7% to $10.7M (expense), Stock-based Compensation in SGA.. decrease of 24% to $450K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.39 to -$0.32.

Employees:	44 as of Dec 31, 2023

Reporting Currency:	U.S. Dollars
Enterprise value:	$56.77M as of Sep 30, 2024
Annual revenue (TTM):	$0.00M as of Sep 30, 2024
EBITDA (TTM):	-$24.03M as of Sep 30, 2024
Net annual income (TTM):	-$23.46M as of Sep 30, 2024
Free cash flow (TTM):	-$19.46M as of Sep 30, 2024
Net Debt Last Fiscal Year:	N/A
Shares outstanding:	59,234,689 as of Nov 12, 2024
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization